Similar articles

• Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.

  Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ; Levetiracetam Monotherapy Study Group. Brodie MJ, et al. Neurology. 2007 Feb 6;68(6):402-8. doi: 10.1212/01.wnl.0000252941.50833.4a. Neurology. 2007. PMID: 17283312 Clinical Trial.
• Lower phenytoin serum levels in persons switched from brand to generic phenytoin.

  Jefferys RJ. Jefferys RJ. Neurology. 2005 Aug 23;65(4):657-8; author reply 657-8. Neurology. 2005. PMID: 16116145 No abstract available.
• Conflicts of interest with the health industry.

  Dubois MY. Dubois MY. Pain Med. 2006 Sep-Oct;7(5):463-5. doi: 10.1111/j.1526-4637.2006.00215_3.x. Pain Med. 2006. PMID: 17014609 Review. No abstract available.
• [Clinical characteristics and treatment for new onset epilepsy in the elderly].

  Akamatsu N. Akamatsu N. Rinsho Shinkeigaku. 2010 Nov;50(11):895. doi: 10.5692/clinicalneurol.50.895. Rinsho Shinkeigaku. 2010. PMID: 21921498 Japanese. No abstract available.
• [Rational combinations of antiepileptic drugs for refractory epilepsy].

  Yoshino A. Yoshino A. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Apr;31(2):65-72. Nihon Shinkei Seishin Yakurigaku Zasshi. 2011. PMID: 21626890 Review. Japanese.